Cedars-Sinai Medical Center

Total Awards: 
13
Approved funds: 
$41,943,802
Institution type: 
Not for profit

Awards to the Institution

Funding
New Faculty Physician Scientist: Robert Baloh Human iPSC modeling and therapeutics for degenerative peripheral nerve disease $3,206,737
Early Translational II: Dan Gazit Systemic Adult Stem Cell Therapy for Osteoporosis-Related Vertebral Compression Fractures $1,927,698
Basic Biology IV: Eduardo Marbán Mechanism of heart regeneration by cardiosphere-derived cells $1,367,604
Disease Team Research I: Eduardo Marbán Autologous cardiac-derived cells for advanced ischemic cardiomyopathy $5,560,232
Tools and Technologies II: Clive Svendsen Use of iPS cells (iPSCs) to develop novels tools for the treatment of spinal muscular atrophy. $1,933,022
Disease Team Therapy Planning I: Dan Gazit Genetically Engineered Mesenchymal Stem Cells for the Treatment of Vertebral Compression Fractures. $109,743
Disease Team Therapy Planning I: Clive Svendsen Stem Cells Secreting GDNF for the Treatment of ALS $89,834
Disease Team Therapy Development - Research: Clive Svendsen Progenitor Cells Secreting GDNF for the Treatment of ALS $17,842,617
iPSC Consortia Award: Clive Svendsen The HD iPSC Consortium: Repeat Length Dependent Phenotypes for Assay Development $300,000
Early Translational IV: Dan Gazit Gene Targeting to Endogenous Stem Cells for Segmental Bone Fracture Healing $5,185,487
Research Leadership 12: Barry Stripp Epithelial progenitors and the stromal niche as therapeutic targets in lung disease $4,841,830
Basic Biology V: Paul Noble Innate Immune Regulation of Lung Alveolar Stem Cell Renewal in Mouse and Man $624,816
Disease Team Planning: Eduardo Marbán {REDACTED} Heart Disease Regenerative Medicine Team Planning Award $46,886
Total:
$43,036,506.00
Icon for xls export

© 2013 California Institute for Regenerative Medicine